# Semaglutide as a promising antiobesity drug

Review · Georgios A. Christou, Niki Katsiki, John Edward Blundell, Gema Frühbeck, Dimitrios Nikiforos Kiortsis

- Archive id: doi:10.1111/obr.12839
- Published: 2019-02-15
- Venue: Obesity Reviews
- DOI: https://doi.org/10.1111/obr.12839
- PMID: 30768766
- Citations: 159
- Source URL: https://doi.org/10.1111/obr.12839
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.